Venous Thrombosis (VT)
Open Solicitation Posted
- Solicitation number
- 80JSC026Q0014
- Agency
-
Johnson Space Center
National Aeronautics and Space Administration
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Houston, Texas, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
NASA Johnson Space Center seeks applied research approaches to surveil, reduce risk of, and prevent or treat venous thrombosis during spaceflight and exploration missions, with quotations due November 20, 2026. The solicitation is RFQ 80JSC026Q0014, issued as a combined synopsis/solicitation under FAR Part 12 for commercial products and services with no set-aside.
Place of performance is Houston, Texas. The NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences), with a 1,000-employee size standard. This is a firm fixed-price procurement with a performance period from January 7, 2027 through September 30, 2031 (approximately 4.75 years following Amendment 002 issued September 28, 2026). Delivery to NASA/JSC must occur within 30 days after receipt of order, FOB Destination.
Work scope includes development and validation of surveillance approaches, point-of-care assessment devices operable in weightlessness or reduced gravity, mechanical countermeasures, and spaceflight or analog research relevant to venous thrombosis. Prospective research and retrospective analysis of existing astronaut imaging datasets and biomarker measurements in stored frozen samples are both acceptable. The contractor must provide all necessary management, labor, materials, equipment, supplies, facilities, and transportation.
Submissions must comply with Dual-Anonymous Peer Review guidelines under NASA's Human Exploration Research Opportunities framework. The anonymized project description is limited to 10 pages, with additional specified limits for statistical approach, data management plan, and budget documentation. A separate non-anonymized section must contain team identities, qualifications, biographical sketches, and commitment letters.
Evaluation uses a trade-off methodology with three factors in descending order of importance: Technical Acceptability (assessed through Scientific Merit Review and Programmatic Relevancy Review), Past Performance (evaluated via CPARS, SAM.gov, and other government sources), and Price. Technical and past performance combined are significantly more important than price.
Notice text
3 versions
Update #3 · Latest ·
Amendment 002:
The purpose of this amendment is to fix admin errors on the CLIN. Please see SF30.
Amendment 001:
The purpose of this amendment is to correct a spelling error on documents from "Venus Thrombosis" to "Venous Thrombosis".
__________________________________________________
Base
Venous Thrombosis RFQ:
This notice is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the FAR Part 12, Acquisition of Commercial Products and Commercial Services. This announcement constitutes the only solicitation; offers are being requested and a written solicitation will not be issued.
This notice is being issued as a Request for Quotations (RFQ) under solicitation number 80JSC026Q0014 for Venous Thrombosis (VT) .
The provisions and clauses in the RFQ are those in effect through FAC 2026-01
The NAICS Code and Size Standard are 541715 and 1000 Employees, respectively. The offeror must state in their offer their size status for this acquisition.
All responsible sources may submit an offer which must be considered by the agency.
Delivery to NASA/JSC is required within 30 days after receipt of order. Delivery must be free on board (FOB) Destination.
The following clauses and provisions are incorporated; full text of the clauses and provisions may be accessed electronically at: FAR - FAR Overhaul - Part 52 | Acquisition.GOV
NFS - https://www.hq.nasa.gov/office/procurement/regs/NFS.pdf
Offerors must provide the information required by FAR 52.212-1, Instructions to Offerors-Commercial Products and Commercial Serviceswhich is incorporated by reference.
The items under this acquisition are subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements.
FAR 52.212-2, Evaluation -- Commercial Products and Commercial Services
The Government will award a contract resulting from this solicitation to the offer responsible, whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors are in descending order of importance and must be used to evaluate offers: Technical Acceptability, Past Performance, and Price. Technical and Past Performance, when combined, are significantly more important than price.
FAR 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services is applicable
NASA Clause 1852.215-84, Ombudsman, is applicable. The Center Ombudsman for this acquisition can be found at: https://www.hq.nasa.gov/office/procurement/regs/Procurement-Ombuds-Comp-Advocate-Listing.pdf
This posting, in addition to any attached documents, will be available on www.Sam.gov. Potential offerors will be responsible for downloading their own copy of this combination synopsis/solicitation and amendments (if any).
Prospective offerors are encouraged to notify this office of their intent to submit an offer. All contractual and technical questions must be submitted electronically via email to John Russo at john.d.russo@nasa.gov and Katelyn Jaime at katelyn.r.jaime@nasa.gov not later than 1:00 PM CST on 10/25/2026. Telephone questions will not be accepted.
Responses to this combined synopsis/solicitation (with concurrence by the offeror’s institutional Authorized Organizational Official (AOR) if applicable) must be received via email no later than 1:00PM CST on 11/20/2026.
The Government is not responsible for any failure attributable to the transmission or receipt of documents submitted using electronic means, including the missing of any established deadlines.
Failure to submit a complete electronic proposal by the due date and time specified for this RFQ must result in the proposal being considered late and must be handled in accordance with FAR 52.212-1 Instructions to Offerors - Commercial Products and Commercial Services.
Update #2 ·
Amendment 001:
The purpose of this amendment is to correct a spelling error on documents from "Venus Thrombosis" to "Venous Thrombosis".
__________________________________________________
Base
Venous Thrombosis RFQ:
This notice is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the FAR Part 12, Acquisition of Commercial Products and Commercial Services. This announcement constitutes the only solicitation; offers are being requested and a written solicitation will not be issued.
This notice is being issued as a Request for Quotations (RFQ) under solicitation number 80JSC026Q0014 for Venous Thrombosis (VT) .
The provisions and clauses in the RFQ are those in effect through FAC 2026-01
The NAICS Code and Size Standard are 541715 and 1000 Employees, respectively. The offeror must state in their offer their size status for this acquisition.
All responsible sources may submit an offer which must be considered by the agency.
Delivery to NASA/JSC is required within 30 days after receipt of order. Delivery must be free on board (FOB) Destination.
The following clauses and provisions are incorporated; full text of the clauses and provisions may be accessed electronically at: FAR - FAR Overhaul - Part 52 | Acquisition.GOV
NFS - https://www.hq.nasa.gov/office/procurement/regs/NFS.pdf
Offerors must provide the information required by FAR 52.212-1, Instructions to Offerors-Commercial Products and Commercial Serviceswhich is incorporated by reference.
The items under this acquisition are subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements.
FAR 52.212-2, Evaluation -- Commercial Products and Commercial Services
The Government will award a contract resulting from this solicitation to the offer responsible, whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors are in descending order of importance and must be used to evaluate offers: Technical Acceptability, Past Performance, and Price. Technical and Past Performance, when combined, are significantly more important than price.
FAR 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services is applicable
NASA Clause 1852.215-84, Ombudsman, is applicable. The Center Ombudsman for this acquisition can be found at: https://www.hq.nasa.gov/office/procurement/regs/Procurement-Ombuds-Comp-Advocate-Listing.pdf
This posting, in addition to any attached documents, will be available on www.Sam.gov. Potential offerors will be responsible for downloading their own copy of this combination synopsis/solicitation and amendments (if any).
Prospective offerors are encouraged to notify this office of their intent to submit an offer. All contractual and technical questions must be submitted electronically via email to John Russo at john.d.russo@nasa.gov and Katelyn Jaime at katelyn.r.jaime@nasa.gov not later than 1:00 PM CST on 10/25/2026. Telephone questions will not be accepted.
Responses to this combined synopsis/solicitation must be received via email no later than 1:00PM CST on 11/20/2026.
The Government is not responsible for any failure attributable to the transmission or receipt of documents submitted using electronic means, including the missing of any established deadlines.
Failure to submit a complete electronic proposal by the due date and time specified for this RFQ must result in the proposal being considered late and must be handled in accordance with FAR 52.212-1 Instructions to Offerors - Commercial Products and Commercial Services.
Update #1 ·
Venus Thrombosis RFQ:
This notice is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the FAR Part 12, Acquisition of Commercial Products and Commercial Services. This announcement constitutes the only solicitation; offers are being requested and a written solicitation will not be issued.
This notice is being issued as a Request for Quotations (RFQ) under solicitation number 80JSC026Q0014 for Venus Thrombosis (VT) .
The provisions and clauses in the RFQ are those in effect through FAC 2026-01
The NAICS Code and Size Standard are 541715 and 1000 Employees, respectively. The offeror must state in their offer their size status for this acquisition.
All responsible sources may submit an offer which must be considered by the agency.
Delivery to NASA/JSC is required within 30 days after receipt of order. Delivery must be free on board (FOB) Destination.
The following clauses and provisions are incorporated; full text of the clauses and provisions may be accessed electronically at: FAR - FAR Overhaul - Part 52 | Acquisition.GOV
NFS - https://www.hq.nasa.gov/office/procurement/regs/NFS.pdf
Offerors must provide the information required by FAR 52.212-1, Instructions to Offerors-Commercial Products and Commercial Serviceswhich is incorporated by reference.
The items under this acquisition are subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements.
FAR 52.212-2, Evaluation -- Commercial Products and Commercial Services
The Government will award a contract resulting from this solicitation to the offer responsible, whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors are in descending order of importance and must be used to evaluate offers: Technical Acceptability, Past Performance, and Price. Technical and Past Performance, when combined, are significantly more important than price.
FAR 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services is applicable
NASA Clause 1852.215-84, Ombudsman, is applicable. The Center Ombudsman for this acquisition can be found at: https://www.hq.nasa.gov/office/procurement/regs/Procurement-Ombuds-Comp-Advocate-Listing.pdf
This posting, in addition to any attached documents, will be available on www.Sam.gov. Potential offerors will be responsible for downloading their own copy of this combination synopsis/solicitation and amendments (if any).
Prospective offerors are encouraged to notify this office of their intent to submit an offer. All contractual and technical questions must be submitted electronically via email to John Russo at john.d.russo@nasa.gov and Katelyn Jaime at katelyn.r.jaime@nasa.gov not later than 1:00 PM CST on 10/25/2026. Telephone questions will not be accepted.
Responses to this combined synopsis/solicitation must be received via email no later than 1:00PM CST on 11/20/2026.
The Government is not responsible for any failure attributable to the transmission or receipt of documents submitted using electronic means, including the missing of any established deadlines.
Failure to submit a complete electronic proposal by the due date and time specified for this RFQ must result in the proposal being considered late and must be handled in accordance with FAR 52.212-1 Instructions to Offerors - Commercial Products and Commercial Services.
Files
Show all 13
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity